This may be owing to ethnic differences in the clinical characteristics of patients with GDM, with Southeast Asian women having the lowest need for insulin treatment [41] and the study population enrolled in our study being based on a nation-wide population, but other studies being based on tertiary hospital-patients [39, 40]. The gene discussed is INS; the disease is gestational diabetes.